ReviewCurrent pharmaceutical biotechnology2012

Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.

Robert E McCullumsmith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.